BIK, the founding member of the BH3-only family proteins: mechanisms of cell death and role in cancer and pathogenic processes

BIK is the founding member of the BH3-only family pro-apoptotic proteins. BIK is predominantly localized in the ER and induces apoptosis through the mitochondrial pathway by mobilizing calcium from the ER to the mitochondria and remodeling the mitochondrial cristae. BIK-mediated apoptosis is mediated by selective activation of BAX. BIK also induces non-apoptotic cell death in certain cell types by unknown mechanisms. BIK is non-essential for animal development, but appears to be functionally redundant for certain developmental functions with BIM. BIK is implicated in the selection of mature B cells in humans. BIK is a pro-apoptotic tumor suppressor in several human tissues and its expression in cancers is prevented by chromosomal deletions encompassing the Bik locus or by epigenetic silencing. BIK appears to be a critical effector in apoptosis induced by toxins, cytokines and virus infection. Several anti-cancer drugs transcriptionally activate Bik gene expression through transcriptional pathways dependent on factors such as E2F and p53 or by removal of epigenetic marks on the chromatin. BIK appears to be a prominent target for anti-cancer drugs that inhibit proteasomal functions. BIK has also been used as a therapeutic molecule in gene therapy-based approaches to treat difficult cancers.

[1]  E. Schmitt,et al.  Activation of multidomain and BH3-only pro-apoptotic Bcl-2 family members in p53-defective cells , 2004, Apoptosis.

[2]  Lin Chen,et al.  Proapoptotic Bak is sequestered by Mcl-1 and Bcl-xL, but not Bcl-2, until displaced by BH3-only proteins. , 2005, Genes & development.

[3]  A. Saltzman,et al.  Transforming Growth Factor-β-Mediated Apoptosis in the Ramos B-Lymphoma Cell Line Is Accompanied by Caspase Activation and Bcl-XLDownregulation , 1998 .

[4]  G. Chinnadurai,et al.  Evidence for Involvement of BH3-Only Proapoptotic Members in Adenovirus-Induced Apoptosis , 2007, Journal of Virology.

[5]  M. Weller,et al.  Adenoviral natural born killer gene therapy for malignant glioma. , 2003, Human gene therapy.

[6]  P. Real,et al.  Transcriptional activation of the proapoptotic bik gene by E2F proteins in cancer cells , 2006, FEBS letters.

[7]  S. Korsmeyer,et al.  Proapoptotic BAX and BAK: A Requisite Gateway to Mitochondrial Dysfunction and Death , 2001, Science.

[8]  B. Emanuel,et al.  Structural analysis of the human pro-apoptotic gene Bik: chromosomal localization, genomic organization and localization of promoter sequences. , 2000, Gene.

[9]  S. Li,et al.  A novel member of the Rhomboid family, RHBDD1, regulates BIK-mediated apoptosis , 2008, Cellular and Molecular Life Sciences.

[10]  A. Strasser,et al.  Concomitant loss of proapoptotic BH3‐only Bcl‐2 antagonists Bik and Bim arrests spermatogenesis , 2005, The EMBO journal.

[11]  G. Chinnadurai,et al.  Functional Dissection of the Pro-apoptotic Protein Bik , 1997, The Journal of Biological Chemistry.

[12]  S. Frank,et al.  The role of dynamin-related protein 1, a mediator of mitochondrial fission, in apoptosis. , 2001, Developmental cell.

[13]  Victor E. Marquez,et al.  Microarray Analysis of Epigenetic Silencing of Gene Expression in the KAS-6/1 Multiple Myeloma Cell Line , 2004, Cancer Research.

[14]  W. Zong,et al.  BH3-only proteins that bind pro-survival Bcl-2 family members fail to induce apoptosis in the absence of Bax and Bak. , 2001, Genes & development.

[15]  E. Clark,et al.  Involvement of Bik, a Proapoptotic Member of the Bcl-2 Family, in Surface IgM-Mediated B Cell Apoptosis1 , 2001, The Journal of Immunology.

[16]  M. Hung,et al.  Enhancement of Bik antitumor effect by Bik mutants. , 2003, Cancer research.

[17]  A. Kraft,et al.  The proteasome inhibitor bortezomib sensitizes cells to killing by death receptor ligand TRAIL via BH3-only proteins Bik and Bim , 2005, Molecular Cancer Therapeutics.

[18]  T. Chittenden,et al.  A conserved domain in Bak, distinct from BH1 and BH2, mediates cell death and protein binding functions. , 1995, The EMBO journal.

[19]  H. McBride,et al.  Endoplasmic reticulum BIK initiates DRP1‐regulated remodelling of mitochondrial cristae during apoptosis , 2005, The EMBO journal.

[20]  G. Shore,et al.  BH-3-only BIK Functions at the Endoplasmic Reticulum to Stimulate Cytochrome c Release from Mitochondria* , 2002, The Journal of Biological Chemistry.

[21]  J. Ryerse,et al.  BH3-only protein BIK induces caspase-independent cell death with autophagic features in Bcl-2 null cells , 2008, Oncogene.

[22]  M. Blanchette,et al.  BH3‐ligand regulates access of MCL‐1 to its E3 ligase , 2005, FEBS letters.

[23]  M. Gouy,et al.  Phylogenomics of life-or-death switches in multicellular animals: Bcl-2, BH3-Only, and BNip families of apoptotic regulators. , 2005, Molecular biology and evolution.

[24]  Y. Tsujimoto,et al.  Proapoptotic BH3-only Bcl-2 family members induce cytochrome c release, but not mitochondrial membrane potential loss, and do not directly modulate voltage-dependent anion channel activity. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[25]  M. Inouye,et al.  NBK/BIK antagonizes MCL-1 and BCL-XL and activates BAK-mediated apoptosis in response to protein synthesis inhibition. , 2007, Genes & development.

[26]  G. Shore,et al.  BH3-only BIK Regulates BAX,BAK-dependent Release of Ca2+ from Endoplasmic Reticulum Stores and Mitochondrial Apoptosis during Stress-induced Cell Death* , 2005, Journal of Biological Chemistry.

[27]  S. Verma,et al.  Phosphorylation of the Pro-apoptotic Protein BIK , 2001, The Journal of Biological Chemistry.

[28]  Shelley E. Brown,et al.  DNA Methyltransferase 1 Knock Down Induces Gene Expression by a Mechanism Independent of DNA Methylation and Histone Deacetylation* , 2004, Journal of Biological Chemistry.

[29]  T. Chittenden,et al.  The pro-apoptotic protein, Bik, exhibits potent antitumor activity that is dependent on its BH3 domain. , 2001, Molecular cancer therapeutics.

[30]  Wei Guo,et al.  Proteasome inhibitors-mediated TRAIL resensitization and Bik accumulation , 2005, Cancer biology & therapy.

[31]  J. Grandis,et al.  Bortezomib induces apoptosis via Bim and Bik up-regulation and synergizes with cisplatin in the killing of head and neck squamous cell carcinoma cells , 2008, Molecular Cancer Therapeutics.

[32]  B. Dörken,et al.  Mcl-1 determines the Bax dependency of Nbk/Bik-induced apoptosis , 2007, The Journal of cell biology.

[33]  F. Sinicrope,et al.  PS-341 (Bortezomib) Induces Lysosomal Cathepsin B Release and a Caspase-2-dependent Mitochondrial Permeabilization and Apoptosis in Human Pancreatic Cancer Cells* , 2006, Journal of Biological Chemistry.

[34]  A. Harris,et al.  BNIP3 Expression Is Linked with Hypoxia-Regulated Protein Expression and with Poor Prognosis in Non–Small Cell Lung Cancer , 2004, Clinical Cancer Research.

[35]  J. Risk,et al.  Bim, Bad and Bmf: intrinsically unstructured BH3-only proteins that undergo a localized conformational change upon binding to prosurvival Bcl-2 targets , 2007, Cell Death and Differentiation.

[36]  S. Korsmeyer,et al.  Solution Structure of the Proapoptotic Molecule BID A Structural Basis for Apoptotic Agonists and Antagonists , 1999, Cell.

[37]  L. Larocca,et al.  Mutations of the BIK gene in human peripheral B‐cell lymphomas , 2003, Genes, chromosomes & cancer.

[38]  Wei Guo,et al.  Bik/NBK accumulation correlates with apoptosis-induction by bortezomib (PS-341, Velcade) and other proteasome inhibitors , 2005, Oncogene.

[39]  B. Dörken,et al.  Expression of the death gene Bik/Nbk promotes sensitivity to drug-induced apoptosis in corticosteroid-resistant T-cell lymphoma and prevents tumor growth in severe combined immunodeficient mice. , 1999, Blood.

[40]  Luca Scorrano,et al.  A distinct pathway remodels mitochondrial cristae and mobilizes cytochrome c during apoptosis. , 2002, Developmental cell.

[41]  Y. Tesfaigzi,et al.  The BH3-only protein Bik/Blk/Nbk inhibits nuclear translocation of activated ERK1/2 to mediate IFNγ-induced cell death , 2008, The Journal of cell biology.

[42]  S. Korsmeyer,et al.  BCL-2, BCL-X(L) sequester BH3 domain-only molecules preventing BAX- and BAK-mediated mitochondrial apoptosis. , 2001, Molecular cell.

[43]  E. White,et al.  Induction of apoptosis by human Nbk/Bik, a BH3-containing protein that interacts with E1B 19K , 1996, Molecular and cellular biology.

[44]  M. Vu,et al.  Proteasomes Modulate Balance Among Proapoptotic and Antiapoptotic Bcl-2 Family Members and Compromise Functioning of the Electron Transport Chain in Leukemic Cells1 , 2001, The Journal of Immunology.

[45]  G. Zhong,et al.  Degradation of the Proapoptotic Proteins Bik, Puma, and Bim with Bcl-2 Domain 3 Homology in Chlamydia trachomatis-Infected Cells , 2005, Infection and Immunity.

[46]  L. Spender,et al.  TGF-β induces apoptosis in human B cells via transcriptional regulation of BIK and BCL-XL , 2009, Cell Death and Differentiation.

[47]  Y. Tu,et al.  Gene Expression Dynamics during Germinal Center Transit in B Cells , 2003, Annals of the New York Academy of Sciences.

[48]  Douglas B. Evans,et al.  Targeted expression of BikDD eradicates pancreatic tumors in noninvasive imaging models. , 2007, Cancer cell.

[49]  B. Dörken,et al.  The apoptosis promoting Bcl-2 homologues Bak and Nbk/Bik overcome drug resistance in Mdr-1-negative and Mdr-1-overexpressing breast cancer cell lines , 2002, Oncogene.

[50]  J. M. Boyd,et al.  Adenovirus E1B 19 kDa and Bcl-2 proteins interact with a common set of cellular proteins. , 1994, Cell.

[51]  G. Shore,et al.  Induction and endoplasmic reticulum location of BIK/NBK in response to apoptotic signaling by E1A and p53 , 2002, Oncogene.

[52]  D. Nance,et al.  Inhibition of Apoptosis in Chlamydia-infected Cells: Blockade of Mitochondrial Cytochrome c Release and Caspase Activation , 1998, The Journal of experimental medicine.

[53]  S. Korsmeyer,et al.  Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programed cell death , 1993, Cell.

[54]  E. Stanley,et al.  Proapoptotic BH3-Only Bcl-2 Family Member Bik/Blk/Nbk Is Expressed in Hemopoietic and Endothelial Cells but Is Redundant for Their Programmed Death , 2004, Molecular and Cellular Biology.

[55]  S. Fox,et al.  Expression of the cell death genes BNip3 and NIX in ductal carcinoma in situ of the breast; correlation of BNip3 levels with necrosis and grade , 2003, The Journal of pathology.

[56]  Xiaodong Wang,et al.  Mule/ARF-BP1, a BH3-Only E3 Ubiquitin Ligase, Catalyzes the Polyubiquitination of Mcl-1 and Regulates Apoptosis , 2005, Cell.

[57]  L. Recht,et al.  High-resolution genome-wide mapping of genetic alterations in human glial brain tumors. , 2005, Cancer research.

[58]  J. Diallo,et al.  Enhanced killing of androgen-independent prostate cancer cells using inositol hexakisphosphate in combination with proteasome inhibitors , 2008, British Journal of Cancer.

[59]  J. M. Boyd,et al.  Bik, a novel death-inducing protein shares a distinct sequence motif with Bcl-2 family proteins and interacts with viral and cellular survival-promoting proteins. , 1995, Oncogene.

[60]  I. Alvarado,et al.  A molecular analysis by gene expression profiling reveals Bik/NBK overexpression in sporadic breast tumor samples of Mexican females , 2005, BMC Cancer.

[61]  S. Srinivasula,et al.  Blk, a BH3-containing Mouse Protein That Interacts with Bcl-2 and Bcl-xL, Is a Potent Death Agonist* , 1998, The Journal of Biological Chemistry.

[62]  K. Coser,et al.  Regulation of expression of BIK proapoptotic protein in human breast cancer cells: p53-dependent induction of BIK mRNA by fulvestrant and proteasomal degradation of BIK protein. , 2006, Cancer research.

[63]  S. Kamel‐Reid,et al.  Quantitative real-time PCR identifies a critical region of deletion on 22q13 related to prognosis in oral cancer , 2002, Oncogene.

[64]  B. Dörken,et al.  Induction of cell death by the BH3‐only Bcl‐2 homolog Nbk/Bik is mediated by an entirely Bax‐dependent mitochondrial pathway , 2003, The EMBO journal.

[65]  Zhifu Sun,et al.  A Gene Expression Signature Predicts Survival of Patients with Stage I Non-Small Cell Lung Cancer , 2006, PLoS medicine.

[66]  B. Dörken,et al.  Loss of the tissue-specific proapoptotic BH3-only protein Nbk/Bik is a unifying feature of renal cell carcinoma , 2006, Cell Death and Differentiation.

[67]  D. Grandér,et al.  Activation of Bak, Bax, and BH3-only Proteins in the Apoptotic Response to Doxorubicin* , 2002, The Journal of Biological Chemistry.

[68]  J. Eberle,et al.  Caspase-independent induction of apoptosis in human melanoma cells by the proapoptotic Bcl-2-related protein Nbk / Bik , 2005, Oncogene.

[69]  E. White,et al.  Tumor Necrosis Factor-α Induces Bax-Bak Interaction and Apoptosis, Which Is Inhibited by Adenovirus E1B 19K* , 2001, The Journal of Biological Chemistry.

[70]  K. Coser,et al.  The Bik BH3-only protein is induced in estrogen-starved and antiestrogen-exposed breast cancer cells and provokes apoptosis. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[71]  M. Hung,et al.  Systemic tumor suppression by the proapoptotic gene bik. , 2002, Cancer research.

[72]  W. Sadee,et al.  5-Aza-2'-deoxycytidine and depsipeptide synergistically induce expression of BIK (BCL2-interacting killer). , 2006, Biochemical and biophysical research communications.

[73]  L. Ramdas,et al.  Altered gene expression in busulfan-resistant human myeloid leukemia. , 2008, Leukemia research.

[74]  S. Korsmeyer,et al.  Bad, a heterodimeric partner for Bcl-xL and Bcl-2, displaces bax and promotes cell death , 1995, Cell.

[75]  Joseph L Goldstein,et al.  Regulated Intramembrane Proteolysis A Control Mechanism Conserved from Bacteria to Humans , 2000, Cell.

[76]  D. Louis,et al.  Mapping of a target region of allelic loss to a 0.5-cM interval on chromosome 22q13 in human colorectal cancer. , 1999, Gastroenterology.

[77]  G. Chinnadurai,et al.  Adenovirus-Induced Apoptosis Requirement of BAX for Efficient , 2002 .

[78]  G. Chinnadurai,et al.  Critical requirement of BAX for manifestation of apoptosis induced by multiple stimuli in human epithelial cancer cells. , 2002, Cancer research.